1
Thomas Terry L, Li Zhongsen: An oleosin 5 regulatory region for the modification of plant seed lipid composition. Rhone Poulenc Agro, Thomas Terry L, Li Zhongsen, sDiGIGLIO Frank S, October 15, 1998: WO/1998/045461 (7 worldwide citation)

The present invention is directed to 5' regulatory regions of an $i(Arabidopsis) oleosin gene. The 5' regulatory regions, when operably linked to either the coding sequence of a heterologous gene or a sequence complementary to a native plant gene, direct expression of the coding sequence or compleme ...


2
Eleftheriadis Alexandros, Fang Yihan, Kalva Hari, Puri Atul, Schmidt Robert L: Format de fichier enregistre pour mpeg-4, System and method for interfacing mpeg-coded audiovisual objects permitting adaptive control. At&T, The Trustees Of Columbia University In The City Of New York, At&T, The Trustees Of Columbia University In The City Of New York, KIRBY EADES GALE BAKER, October 15, 1998: CA2257577 (6 worldwide citation)

The invention provides a system and method allowing the adaptation of a nonadaptive system for playing/browsing coded audiovisual objects, such as the parametric system of MPEG-4. The system of the invention is referred to as the programmatic system, and incorporates adaptivity on top of the paramet ...


3
Kuckes Arthur F: Determination de proximite electromagnetique dans le champ proche, Near field electromagnetic proximity determination. Vector Magnetics, Halliburton Energy Services, EMERY JAMIESON, October 15, 1998: CA2279539 (5 worldwide citation)

A method and apparatus for precise measurement of the distance and direction from a magnetic field sensor (30) to a nearby magnetic field source includes an elongated iron core solenoid (50) driven by a repetitive, nonsinusoidal current source (56). In the near field the solenoid (50) has two spaced ...


4
Trozera Thomas, Gomringer Gary: Method for manufacturing a stent. Interventional Technologies, KLICPERA Michael E, October 15, 1998: WO/1998/045506 (4 worldwide citation)

Disclosed herewithin is a method of fabricating a stent which involves processing a tubular member whereby no connection points to join the edges of a flat pattern are necessary. The method includes the steps of removing contaminates from a tubular member (20), coating the outside surface of the tub ...


5
Simpson Stephen Walter: Weld quality measurement. The University Of Sydney, Simpson Stephen Walter, F B RICE 605 Darling StreetBalmain NSW 2041, October 15, 1998: WO/1998/045078 (3 worldwide citation)

This invention concerns weld quality measurement. In particular it concerns an apparatus and a process for measuring on-line, while the welding process is under way, the quality of the resulting weldment. The invention is applicable to spray-transfer gas-metal arc welding, short-circuiting transfer ...


6
Tornquist Anders, Andersson Matts: Configuration et systeme de fabrication de produits dentaires et transmission dinformations, Arrangement and system for production of dental products and transmission of information. Nobel Biocare, Nobel Biocare, FETHERSTONHAUGH & CO, October 15, 1998: CA2285326 (3 worldwide citation)

An operating site is used to assemble individually designed dental products, for example distancing pieces, bridges, etc. Each product consists of two or more structural elements. The operating site is provided with computer equipment which can reproduce a simulated model of the jaw, dentine, implan ...


7
Adkisson Huston D: Neocartilage et ses methodes dutilisation, Neocartilage and methods of use. Barnes Jewish Hospital, Barnes Jewish Hospital, SMART & BIGGAR, October 15, 1998: CA2285382 (2 worldwide citation)

Disclosed are neocartilage compositions characterized by having multiple layers of cells, said cells being surrounded by a substantially continuous insoluble glycosaminoglycan and collagen-enriched hyaline extra-cellular matrix, and which neocartilage phospholipids are advantageously enriched in ant ...


8
Baca Manuel, Wells James A, Presta Leonard G, Lowman Henry B, Chen Yvonne Man Yee: Anticorps anti-vegf, Anti-vegf antibodies. Genentech, Genentech, DENNISON ASSOCIATES, October 15, 1998: CA2286330 (2 worldwide citation)

Humanized and variant anti-VEGF antibodies and vari-ous uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced pro-liferation of endothelial cells in vitro, and inhibit tumor growth in vivo.


9
Baca Manuel, Wells James A, Presta Leonard G, Lowman Henry B, Chen Yvonne Man Yee: Anti-vegf antibodies. Genentech, Baca Manuel, Wells James A, Presta Leonard G, Lowman Henry B, Chen Yvonne Man Yee, DREGER Walter H, October 15, 1998: WO/1998/045331 (2 worldwide citation)

Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells $i(in vitro), and inhibit tumor growth $i(in vivo).


10
Larkin Sarah, Moore Candace, Albrandt Keith, Young Andrew, Beaumont Kevin: Novel uncoupling protein and methods of use. Amylin Pharmaceuticals, Larkin Sarah, Moore Candace, Albrandt Keith, Young Andrew, Beaumont Kevin, DUFT Bradford J, October 15, 1998: WO/1998/045313 (2 worldwide citation)

A novel uncoupling protein, which we have designated UCP-3, that is expressed in skeletal muscle and brown adipose tissue (BAT), and nucleic acid molecules which encode for said novel protein, are described. Methods of screening for compounds that regulate the expression and the activity of UCP-3 ar ...